Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • CMAI Welcomes Governments Latest Notification on Excluding Loose Garments from Legal Metrology (Packaged Commodities) Rules Lifestyle
  • Boisar witnesses property price appreciation of 5% in last 3 years Business
  • 121 Finance Acquires AcceptMyInvoice.com to Remove Friction in Trade Credit for MSMEs Business
  • Kingston Celebrates Its 35th Year Anniversary with its New Micro-film Business
  • Visionary Voices: Pre-Budget Quotes from Entrepreneurs and Leaders Business
  • “Shuddhi Ayurveda” focuses on the holistic improvement of human health Business
  • M1xchange offers ‘Small to Small Factoring’ in partnership with YES BANK and RBL Bank Business
  • Simpolo, the Fastest Growing Premium Brand in the Indian Ceramic Industry Opened its 100th Showroom Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Participants witness dramatic improvements in wellness parameters after 1 month on Yuvaap’s weight loss program Health
  • The Painless Path to Cosmetic Hair Regrowth Health
  • Insights from Leading Paediatricians: The Vital Role of a Nutritious Diet for Children Health
  • Non Certified Dental Crowns Spreading Cancer in India Health
  • Pink Nutrition: Mother’s Diet as the First Shield Against Breast Cancer Health
  • Public Health Service via Jijau Social Foundation – An Inspiring Presence by Hon. Speaker Shri Rahul Narwekar Health

Recent Posts

  • NAMO SAMVEDANA DIWAS: SVNM Trust’s Commitment to 200 Free Eye Surgeries on the Occasion of the 76th Birthday of Hon’ble Prime Minister Shri Narendra Modi
  • Essential Baby Travel Gear Every Parent Needs – Recommended by Loopie
  • 25th CII Energy Efficiency Summit: Energy Efficiency Takes the Next Leap with AI, Electrification and Innovation
  • MotionGravity Develops Human Authenticity Registry to Bring Paid, Consent-Based AI Participation to Everyday People
  • Wealthy Nivesh Multi-Asset FoF PMS Reaches 10-Month Milestone Across Volatile Market Cycles

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Skin Deep Confidence: Edorica’s Minimalist Revolution in Skincare Business
  • AcreRise Named ‘Real Estate Developer of the Year’ at the Times Business Awards-2026 Business
  • Sunpure receives patent for Curcuminoids Complex AKTIV C5 (CURCUBOOST®) Health
  • Aaiji Group Elevates Dholera SIR’s Real Estate Landscape with Innovative Developments Business
  • Prominent Political, Cinema, Social Welfare and Industrial Personalities Honoured In Champion of Change Award Maharashtra 2021 Press Release
  • DEV IT Bags Another ~₹5.15 Crore Order from NICSI Business
  • Très 2026 Returns to Andaz Delhi: Unveiling India’s Premier Boutique Travel Showcase Business
  • The Rising Need for Insurance in Gated Communities in India – Ethika Leads the Way Forward Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme